United Therapeutics (UTHR) Revenue Growth (1y) (2010 - 2026)
United Therapeutics (UTHR) Revenue Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.91 Bn | 88.04 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.05 Bn | 20.89 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 14.92% |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | 333.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.62% |
| Dec 31, 2025 | 7.38% |
| Sep 30, 2025 | 6.76% |
| Jun 30, 2025 | 11.71% |
| Mar 31, 2025 | 17.22% |
| Dec 31, 2024 | 19.72% |
| Sep 30, 2024 | 22.89% |
| Jun 30, 2024 | 19.85% |
| Mar 31, 2024 | 33.70% |
| Dec 31, 2023 | 25.07% |
| Sep 30, 2023 | 18.10% |
| Jun 30, 2023 | 27.76% |
| Mar 31, 2023 | 9.74% |
| Dec 31, 2022 | 18.38% |
| Sep 30, 2022 | 16.03% |
| Jun 30, 2022 | 4.57% |
| Mar 31, 2022 | 21.84% |
| Dec 31, 2021 | 7.87% |
| Sep 30, 2021 | 17.00% |
| Jun 30, 2021 | 23.34% |